Susquehanna International Group
FOLD

Susquehanna International Group’s Amicus Therapeutics FOLD Stock Holding History

Susquehanna International Group’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.94M Sell
134,100
-316,100
-70% -$4.53M ﹤0.01% 6257
2025
Q4 		$6.41M Buy
450,200
+28,500
+7% +$280K ﹤0.01% 3654
2025
Q3 		$3.32M Buy
+421,700
New +$3M ﹤0.01% 4779
2025
Q2 		– Sell
-32,700
Closed -$267K – 12975
2025
Q1 		$267K Sell
32,700
-68,200
-68% -$631K ﹤0.01% 10322
2024
Q4 		$950K Sell
100,900
-113,400
-53% -$1.18M ﹤0.01% 7086
2024
Q3 		$2.29M Buy
214,300
+97,600
+84% +$1.06M ﹤0.01% 5014
2024
Q2 		$1.16M Buy
116,700
+52,400
+81% +$538K ﹤0.01% 6242
2024
Q1 		$757K Sell
64,300
-77,000
-54% -$985K ﹤0.01% 7533
2023
Q4 		$2.01M Buy
141,300
+81,600
+137% +$926K ﹤0.01% 5343
2023
Q3 		$726K Buy
59,700
+19,400
+48% +$250K ﹤0.01% 7365
2023
Q2 		$506K Buy
+40,300
New +$478K ﹤0.01% 8284
2023
Q1 		– Sell
-131,100
Closed -$1.6M – 12852
2022
Q4 		$1.6M Sell
131,100
-45,700
-26% -$514K ﹤0.01% 5139
2022
Q3 		$1.85M Buy
176,800
+165,800
+1,507% +$1.85M ﹤0.01% 5076
2022
Q2 		$118K Sell
11,000
-1,300
-11% -$10.7K ﹤0.01% 11304
2022
Q1 		$116K Sell
12,300
-2,400
-16% -$22.5K ﹤0.01% 11791
2021
Q4 		$170K Sell
14,700
-98,600
-87% -$1.1M ﹤0.01% 11640
2021
Q3 		$1.08M Buy
113,300
+66,300
+141% +$678K ﹤0.01% 7346
2021
Q2 		$453K Sell
47,000
-214,100
-82% -$2.09M ﹤0.01% 9812
2021
Q1 		$2.58M Buy
261,100
+174,000
+200% +$2.69M ﹤0.01% 5310
2020
Q4 		$2.01M Buy
87,100
+31,300
+56% +$640K ﹤0.01% 5082
2020
Q3 		$788K Sell
55,800
-14,800
-21% -$216K ﹤0.01% 6699
2020
Q2 		$1.06M Sell
70,600
-9,400
-12% -$115K ﹤0.01% 5779
2020
Q1 		$739K Buy
80,000
+23,900
+43% +$227K ﹤0.01% 6068
2019
Q4 		$546K Sell
56,100
-9,100
-14% -$83.3K ﹤0.01% 6816
2019
Q3 		$523K Sell
65,200
-160,400
-71% -$1.74M ﹤0.01% 7219
2019
Q2 		$2.81M Sell
225,600
-235,300
-51% -$2.99M ﹤0.01% 3545
2019
Q1 		$6.27M Buy
460,900
+361,900
+366% +$4.42M ﹤0.01% 2203
2018
Q4 		$948K Sell
99,000
-134,100
-58% -$1.47M ﹤0.01% 4780
2018
Q3 		$2.82M Sell
233,100
-66,100
-22% -$924K ﹤0.01% 3451
2018
Q2 		$4.67M Sell
299,200
-1,734,000
-85% -$26.2M ﹤0.01% 2789
2018
Q1 		$30.6M Buy
2,033,200
+563,800
+38% +$8.58M 0.01% 923
2017
Q4 		$21.1M Sell
1,469,400
-69,500
-5% -$955K 0.01% 1218
2017
Q3 		$23.2M Buy
1,538,900
+1,025,600
+200% +$13.6M 0.01% 1120
2017
Q2 		$5.17M Buy
513,300
+200,900
+64% +$1.62M ﹤0.01% 2371
2017
Q1 		$2.23M Buy
312,400
+72,700
+30% +$460K ﹤0.01% 3508
2016
Q4 		$1.19M Buy
239,700
+39,800
+20% +$275K ﹤0.01% 5142
2016
Q3 		$1.48M Buy
199,900
+22,200
+12% +$150K ﹤0.01% 4073
2016
Q2 		$970K Buy
177,700
+64,600
+57% +$452K ﹤0.01% 4942
2016
Q1 		$956K Sell
113,100
-139,300
-55% -$987K ﹤0.01% 5177
2015
Q4 		$2.45M Buy
252,400
+187,400
+288% +$1.69M ﹤0.01% 3646
2015
Q3 		$909K Sell
65,000
-337,100
-84% -$5.29M ﹤0.01% 5957
2015
Q2 		$5.69M Sell
402,100
-52,500
-12% -$631K ﹤0.01% 2714
2015
Q1 		$4.95M Buy
454,600
+36,800
+9% +$324K ﹤0.01% 2758
2014
Q4 		$3.48M Buy
417,800
+317,900
+318% +$2.18M ﹤0.01% 3484
2014
Q3 		$594K Buy
+99,900
New +$523K ﹤0.01% 6897
2014
Q2 		– Sell
-11,800
Closed -$24K – 9861
2014
Q1 		$24K Buy
11,800
+1,400
+13% +$3.5K ﹤0.01% 8774
2013
Q4 		$24K Buy
+10,400
New +$22.8K ﹤0.01% 8888
2013
Q3 		– Sell
-17,700
Closed -$41K – 8503
2013
Q2 		$41K Buy
+17,700
New +$54.4K ﹤0.01% 8013

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Susquehanna International Group's FOLD Position: Q1 2026 in Review

Susquehanna International Group increased its Amicus Therapeutics (FOLD) stake by 3.2% in Q1 2026, buying an estimated $65.6K and bringing the position to 149,341 shares worth $2.16M. The position accounts for ﹤0.01% of the portfolio, ranked #5998.

Susquehanna International Group first reported a position in FOLD in Q3 2013 and has held it in 47 quarters since. The position peaked at $16.9M in Q1 2018. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Susquehanna International Group held 149,341 shares of Amicus Therapeutics worth $2.16M as of Q1 2026.
  • Susquehanna International Group bought 4,578 Amicus Therapeutics shares in Q1 2026, an estimated $65.6K.
  • Amicus Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #5998 holding.
  • Susquehanna International Group first reported a position in Amicus Therapeutics in Q3 2013 and has held it in 47 quarters since.
  • Susquehanna International Group's Amicus Therapeutics position peaked at $16.9M in Q1 2018.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.